Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Transgene
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
Young Adult Survivors United
Numab Therapeutics AG
Eli Lilly and Company
Mayo Clinic
Immodulon Therapeutics Ltd
Rain Oncology Inc
Pfizer
Hoffmann-La Roche
Aristotle University Of Thessaloniki
University of Pennsylvania
Pfizer
Bristol-Myers Squibb
Nektar Therapeutics
MacroGenics
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Daiichi Sankyo
National Institutes of Health Clinical Center (CC)
Cambridge University Hospitals NHS Foundation Trust
Tocagen Inc.
Yale University
CureOne
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
MedInnovation GmbH
The Cleveland Clinic
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center